Raimar Löbenberg
Chairman bei DEFENCE THERAPEUTICS INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Raimar Löbenberg is the founder of RS Therapeutics, Inc. He currently holds the position of Chairman at Defence Therapeutics Inc and Independent Director at BioNxt Solutions, Inc. He is also the Co-Managing Director at Vektor Pharma TF GmbH.
In addition, he has been a Professor of Pharmacy & Pharmaceutical at the University of Alberta since 2000.
Previously, he served as the President of the Canadian Society for Pharmaceutical Sciences from 2014 to 2015.
Dr. Löbenberg obtained his doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main and his undergraduate degree from The Johannes Gutenberg University of Mainz.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIONXT SOLUTIONS INC
4,72% | 03.04.2023 | 5 000 000 ( 4,72% ) | 2 Mio $ | 31.03.2024 |
| 02.11.2023 | 100 000 ( 0,22% ) | 125 000 $ | 31.03.2024 |
Aktive Positionen von Raimar Löbenberg
| Unternehmen | Position | Beginn |
|---|---|---|
| BIONXT SOLUTIONS INC. | Director/Board Member | 10.12.2018 |
| DEFENCE THERAPEUTICS INC. | Chairman | 05.01.2021 |
| University of Alberta | Corporate Officer/Principal | 01.01.2000 |
| RS Therapeutics, Inc. | Founder | - |
Vektor Pharma TF GmbH
 Vektor Pharma TF GmbH Pharmaceuticals: MajorHealth Technology Vektor Pharma TF GmbH engages in the development and production of transdermal systems. It is a narcotics company that focuses on the research, development and production of therapeutic films for pharmaceuticals, cosmetics and food. The firm offers formulation development, pharmaceutical analysis, machinery for development and production, and consultation products. The company was founded in 2009 and is headquartered in Uttenweiler, Germany. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Raimar Löbenberg
| Unternehmen | Position | Ende |
|---|---|---|
| Canadian Society for Pharmaceutical Sciences | President | 01.01.2015 |
Ausbildung von Raimar Löbenberg
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
| The Johannes Gutenberg University of Mainz | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIONXT SOLUTIONS INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Canadian Society for Pharmaceutical Sciences | |
| RS Therapeutics, Inc. | |
Vektor Pharma TF GmbH
Vektor Pharma TF GmbH Pharmaceuticals: MajorHealth Technology Vektor Pharma TF GmbH engages in the development and production of transdermal systems. It is a narcotics company that focuses on the research, development and production of therapeutic films for pharmaceuticals, cosmetics and food. The firm offers formulation development, pharmaceutical analysis, machinery for development and production, and consultation products. The company was founded in 2009 and is headquartered in Uttenweiler, Germany. | Health Technology |
| Defence Therapeutics Inc |
